Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's ...

The "Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's offering. An active pharmaceutical ...

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

Evonik, one of the world's leading specialty chemicals companies, is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The ...

DUBLIN--(BUSINESS WIRE)--The "United States Active Pharmaceutical Ingredients Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ...

Dublin, May 08, 2026 (GLOBE NEWSWIRE)-- The "Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...

Biologics Active Pharmaceutical Ingredient (API) Market · GlobeNewswire Inc. The biologics active pharmaceutical ingredient (API) market has experienced significant growth in recent years, with ...

Protein aggregation and active principle ingredients (API) stability are factors that ultimately impact both the usability and quality of many biopharmaceutical products, especially injectables. The ...

Japanese pharmaceutical contract development and manufacturing organization (CDMO)Peptistarhas integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) system into its facility for ...

Natural active pharmaceutical ingredients – especially biotech-based – are “core buy-and-build terrain” for Astorg, Nicolas Marien, partner, told PE Hub. “The market is fragmented, demand is resilient ...

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business.

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...